Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.70 |
| ▸ | APP | P05067 | 1/20 | 0.59 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.58 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.51 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4351218 | 1.00 | TDP1 (0.70) | TDP1APPALOX5HCAR2FFAR1 | |
| SCHEMBL13557789 | 0.91 | TDP1 (0.68) | TDP1APPALOX5HCAR2FFAR1 | |
| SCHEMBL8817029 | 0.90 | TDP1 (0.66) | TDP1ALOX5FFAR1NPC1RAB9A | |
| SCHEMBL873120 | 0.90 | TDP1 (0.66) | TDP1APPALOX5HCAR2NPC1 | |
| SCHEMBL5358430 | 0.89 | TDP1 (0.57) | TDP1APPALOX5HCAR2FFAR1 | |
| SCHEMBL22832718 | 0.89 | TDP1 (0.81) | TDP1APPALOX5HCAR2FFAR1 | |
| SCHEMBL1629040 | 0.88 | TDP1 (0.64) | TDP1ALOX5FFAR1NPC1RAB9A | |
| SCHEMBL473563 | 0.88 | TDP1 (0.64) | TDP1APPALOX5HPGDCTSK | |
| SCHEMBL17714614 | 0.88 | TDP1 (0.59) | TDP1APPALOX5HCAR2FFAR1 | |
| SCHEMBL2679121 | 0.87 | FFAR1 (0.61) | TDP1APPALOX5FFAR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 683 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| WO-2025202258-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-10-02 | — | — | WO | claimed |
| CN-119799410-A | Aroma molecule for reducing respiratory tract irritation feeling and biological evaluation method thereof | 四川三联新材料有限公司 | 2025-04-11 | — | — | CN | claimed |
| WO-2025056452-A1 | PROCESS TO PRODUCE MATERIALS | UNILEVER IP HOLDINGS B.V. (NL) | 2025-03-20 | — | — | WO | claimed |
| WO-2025059442-A1 | MODULATING PLANT RESPONSES TO STRESS AND GROWTH WITH CHEMICALS | REMOTE EPIGENETICS INC. (US) | 2025-03-20 | — | — | WO | claimed |
| WO-2025057484-A1 | LACTIC ACID BACTERIA-CONTAINING BEVERAGE, METHOD FOR PRODUCING SAID BEVERAGE, AND METHOD FOR IMPROVING FLAVOR OF SAID BEVERAGE | アサヒグループホールディングス株式会社 | 2025-03-20 | — | — | WO | claimed |
| WO-2025054345-A1 | GENETIC ELEMENTS FOR ADJUSTMENT OF EXPRESSION | Remedium Bio, Inc. (US) | 2025-03-13 | — | — | WO | claimed |
| WO-2025051371-A1 | A FRAGRANCE PASTILLE | SYMRISE AG (DE) | 2025-03-13 | — | — | WO | claimed |
| WO-2025045354-A1 | A FRAGRANCE TABLET | SYMRISE AG (DE) | 2025-03-06 | — | — | WO | claimed |
| WO-2025045353-A1 | A FRAGRANCE POD | SYMRISE AG (DE) | 2025-03-06 | — | — | WO | claimed |
| US-20090092568-A1 | DEODORIZING COMPOSITION AND METHOD OF FORMING THEREOF | ZORBX INC. (US) | 2009-04-09 | — | — | US | claimed |
| CN-101386724-A | Application of vegetable oil, ink compound and high boiling point solvent water-scraped without set-off intaglio ink composition | GUANBAO FAN (CN) | 2009-03-18 | — | — | CN | claimed |
| EP-1697386-B1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GEN ELECTRIC (US) | 2007-10-10 | — | — | EP | claimed |
| EP-1716159-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | General Electronic Company (US) | 2006-11-02 | — | — | EP | claimed |
| EP-1697386-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | General Electric Company A Corporation of the State of New York (US) | 2006-09-06 | — | — | EP | claimed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | claimed |
| WO-2005066187-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| WO-2005066186-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | TDP1 3632/4885APP 505/4885ALOX5 356/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | TDP1 3581/4885APP 717/4885ALOX5 340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.